Credit Suisse reiterates its "outperform" rating on SXC Health Solutions (SXCI +4.1%) and says...
Credit Suisse reiterates its "outperform" rating on SXC Health Solutions (SXCI +4.1%) and says the next major catalyst for the company will be its earnings forecasts in its Q2 results. The vote of confidence comes after shareholders approved SXC's merger with Catalyst Health Solutions (CHSI) on Monday.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs